Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

More articles by this author

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...